REPL- Replimune Group, Inc.

Name: Replimune Group, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. REPL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Astley-Sparke Philip	1.43M	$4.78M	-
CEO	Patel Sushil	533.6K	$1.78M	-
Other	Xynos Konstantinos	199.7K	$666.9K	-
CFO	Hill Emily Luisa	194.4K	$649.2K	-
Other	Schwendenman Andrew	78.3K	$261.5K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 9, 2025	Dhingra Kapil	Director	Sale+OE	3,169	$10.40	$32,957.60	-100%	-16.3%	-
Dec 2, 2025	Patel Sushil64	Chief Executive Officer	Sell	10,000	$11.13	$111,300.00	-2.9%	-28.4%	-
Nov 17, 2025	Sarchi Christopher48	Chief Commercial Officer	Sell	5,208	$9.10	$47,392.80	-4.1%	-17.2%	-
Nov 17, 2025	Xynos Konstantinos50	Chief Medical Officer	Sell	7,248	$9.10	$65,956.80	-4.9%	-17.2%	-
Aug 15, 2025	Hill Emily Luisa61	Chief Financial Officer	Sell	9,154	$5.37	$49,156.98	-6.4%	+61.5%	-
May 20, 2025	Xynos Konstantinos50	Chief Medical Officer	Sell	7,952	$8.06	$64,093.12	-5.1%	-42.0%	-
May 20, 2025	Schwendenman Andrew	Chief Accounting Officer	Sell	3,287	$8.05	$26,460.35	-4.6%	-42.0%	-
May 20, 2025	Patel Sushil64	Chief Executive Officer	Sell	25,105	$8.06	$202,346.30	-6.8%	-42.0%	-
May 20, 2025	Hill Emily Luisa61	Chief Financial Officer	Sell	2,535	$8.05	$20,406.75	-1.7%	-42.0%	-
May 20, 2025	Sarchi Christopher48	Chief Commercial Officer	Sell	3,749	$8.05	$30,179.45	-2.8%	-42.0%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC